CR20120614A - Derivados de amino-tropano - Google Patents

Derivados de amino-tropano

Info

Publication number
CR20120614A
CR20120614A CR20120614A CR20120614A CR20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A CR 20120614 A CR20120614 A CR 20120614A
Authority
CR
Costa Rica
Prior art keywords
lower alkyl
amino
tropan
derivatives
tropan derivatives
Prior art date
Application number
CR20120614A
Other languages
English (en)
Inventor
Sabine Kolczewski
Emmanuel Pinard
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20120614A publication Critical patent/CR20120614A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención, se refiere a compuestos de la fórmula general I, en donde, R1, R2 y R3, son, de una forma independiente la una con respecto a la otra, hidrógeno, alquilo inferior, alcoxi inferior, cicloalquilo, alquilo inferior sustituido por halógeno, ó S-alquilo inferior; o a sales de adición de ácidos, farmacéuticamente aceptables, a una mezcla racémica, o sus correspondientes enantiómeros y / o isómeros ópticos de ésta.
CR20120614A 2010-06-22 2012-12-05 Derivados de amino-tropano CR20120614A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10166757 2010-06-22

Publications (1)

Publication Number Publication Date
CR20120614A true CR20120614A (es) 2013-01-11

Family

ID=44310862

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120614A CR20120614A (es) 2010-06-22 2012-12-05 Derivados de amino-tropano

Country Status (24)

Country Link
US (1) US8153653B2 (es)
EP (1) EP2585456B1 (es)
JP (1) JP5546684B2 (es)
KR (1) KR101445016B1 (es)
CN (1) CN102947297B (es)
AR (1) AR081961A1 (es)
AU (1) AU2011269145A1 (es)
BR (1) BR112012032576A2 (es)
CA (1) CA2801458C (es)
CL (1) CL2012003552A1 (es)
CO (1) CO6630160A2 (es)
CR (1) CR20120614A (es)
EA (1) EA201291374A1 (es)
EC (1) ECSP12012347A (es)
ES (1) ES2550831T3 (es)
IL (1) IL222998A0 (es)
MA (1) MA34251B1 (es)
MX (1) MX2012013820A (es)
PE (1) PE20130317A1 (es)
PH (1) PH12012502339A1 (es)
SG (1) SG186329A1 (es)
TW (1) TWI417097B (es)
WO (1) WO2011161006A1 (es)
ZA (1) ZA201209248B (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707636A (pt) * 1996-02-22 1999-07-27 Neurosearch As Composto composição farmacêutica uso de um composto e processos para preparar composto e para tratar um distúrbio ou doença de um organismo animal vivo
US5834484A (en) * 1997-03-12 1998-11-10 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Cocaine analogs
ATE374610T1 (de) * 2003-09-09 2007-10-15 Hoffmann La Roche 1-(2-amino-benzoyl)-piperazin-derivate als glycin-aufnahmehemmer zur behandlung von psychosen
FR2861076B1 (fr) 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique
AU2005243192A1 (en) * 2004-04-29 2005-11-24 Merck & Co., Inc. Azetidine glycine transporter inhibitors
FR2873693B1 (fr) * 2004-07-29 2006-09-15 Sanofi Synthelabo Derives d'amino-tropane, leur preparation et leur application en therapeutique
GB0428231D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
CA2593453A1 (en) * 2005-01-06 2006-07-13 F. Hoffmann-La Roche Ag Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
TW200846328A (en) * 2007-02-01 2008-12-01 Glaxo Group Ltd GlyT1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
WO2010020548A1 (en) * 2008-08-20 2010-02-25 F. Hoffmann-La Roche Ag Glyt1 receptor antagonists

Also Published As

Publication number Publication date
HK1179606A1 (zh) 2013-10-04
IL222998A0 (en) 2013-02-03
WO2011161006A1 (en) 2011-12-29
MA34251B1 (fr) 2013-05-02
ZA201209248B (en) 2013-08-28
JP2013529607A (ja) 2013-07-22
CL2012003552A1 (es) 2013-04-12
TWI417097B (zh) 2013-12-01
PH12012502339A1 (en) 2013-02-11
CN102947297B (zh) 2015-12-16
US20110312993A1 (en) 2011-12-22
TW201206438A (en) 2012-02-16
US8153653B2 (en) 2012-04-10
CN102947297A (zh) 2013-02-27
KR20130029414A (ko) 2013-03-22
SG186329A1 (en) 2013-01-30
JP5546684B2 (ja) 2014-07-09
CA2801458A1 (en) 2011-12-29
ES2550831T3 (es) 2015-11-12
ECSP12012347A (es) 2013-01-31
AR081961A1 (es) 2012-10-31
EP2585456B1 (en) 2015-09-16
CO6630160A2 (es) 2013-03-01
PE20130317A1 (es) 2013-03-11
BR112012032576A2 (pt) 2016-11-22
KR101445016B1 (ko) 2014-09-26
EA201291374A1 (ru) 2013-06-28
MX2012013820A (es) 2013-01-28
EP2585456A1 (en) 2013-05-01
CA2801458C (en) 2018-10-30
AU2011269145A1 (en) 2012-11-08

Similar Documents

Publication Publication Date Title
UY33226A (es) Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6
UY33227A (es) Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
AR082154A1 (es) DERIVADOS DE PIRAZOLO[1,5-a]PIRIMIDINA COMO MODULADORES DE IRAK4
CR20120053A (es) Compuestos y metodos inhibidores de jak de pirazolopirimidina
CR20120410A (es) Pirrolidina-2-carboxamidas sustituidas
CR20140238A (es) Derivados nucleósidos con sustitución 2´, 4´- difluoro-2´-metilo como inhibidores de la replicación del arn del vhc
CR20130537A (es) Compuestos heterocíclicos como inhibidores de cinasas
CR20140042A (es) Indazoles
CO6831982A2 (es) Pirazolo[4,3-d]pirimidinas útiles como inhibidores de cinasas
CR20130369A (es) Novedosos derivados heterocíclicos
CR20130476A (es) Derivados de pirazolidin-3-ona
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
CL2010000253A1 (es) Procedimiento de preparacion de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable; y uno de los compuestos intermediarios considerados.
EA201391206A1 (ru) Способы синтеза производных предшественника молибдоптерина z
ECSP13012548A (es) Inhibidores de oxadiazol de la producción de leucotrienos.
CR20110275A (es) 3-aminociclopentancarboxamidas como moduladores del receptor quimiocina
CR20150158A (es) Derivados de etinilo como moduladores de receptor de actividad mglur5
EA201200123A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
EA201000397A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA200900944A1 (ru) Новый способ получения кристаллической формы v агомелатина
CR20150143A (es) Derivados de etinilo como moduladores del receptor de actividad mglur5
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
UA113223C2 (xx) Арилетинілпіримідини
EA201490536A1 (ru) Новая кристаллическая форма